Why LifeMD, Inc.’s (LFMD) Stock Is Down 5.43%

By Cynthia McLaughlin
May 08, 2026
Featured Tickers:

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate LifeMD, Inc. before investing.

In this article, we go over a few key elements for understanding LifeMD, Inc.’s stock price such as:

  • LifeMD, Inc.’s current stock price and volume
  • Why LifeMD, Inc.’s stock price changed recently
  • Upgrades and downgrades for LFMD from analysts
  • LFMD’s stock price momentum as measured by its relative strength

About LifeMD, Inc. (LFMD)

Before we jump into LifeMD, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men’s telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men’s health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

Want to learn more about LifeMD, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about LifeMD, Inc..

Learn More About A+ Investor

LifeMD, Inc.’s Stock Price as of Market Close

As of May 08, 2026, 10:32 AM, CST, LifeMD, Inc.’s stock price was $4.625.

LifeMD, Inc. is up 3.01% from its previous closing price of $4.490.

During the last market session, LifeMD, Inc.’s stock traded between $4.460 and $4.680. Currently, there are approximately 47.34 million shares outstanding for LifeMD, Inc..

LifeMD, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

LifeMD, Inc. Stock Price History

LifeMD, Inc.’s (LFMD) price is currently down 1.18% so far this month.

During the month of May, LifeMD, Inc.’s stock price has reached a high of $5.380 and a low of $4.330.

Over the last year, LifeMD, Inc. has hit prices as high as $15.840 and as low as $2.560. Year to date, LifeMD, Inc.’s stock is up 35.63%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused LifeMD, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 07, 2026, there was 1 analyst who downgraded LifeMD, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate LifeMD, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on LifeMD, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

LifeMD, Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about LifeMD, Inc. (LFMD) by visiting AAII Stock Evaluator.

Relative Price Strength of LifeMD, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 07, 2026, LifeMD, Inc. has a weighted four-quarter relative price strength of -4.52%, which translates to a Momentum Score of 42 and is considered to be Average.

Want to learn more about how LifeMD, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

LifeMD, Inc. Stock Price: Bottom Line

As of May 8, 2026, LifeMD, Inc.’s stock price is $4.625, which is up 3.01% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like LifeMD, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
High Relative Dividend
Yield Screen:
8.7% Compared to S&P 500
at only 6.9%

Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.